Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

A man had a rare stroke possibly due to taking finasteride, which might have increased his hormone levels causing a blood clot. His memory loss didn't fully recover even after stopping the medication.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Patients follow treatment well, but many change medicines; good information helps compliance.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Saw palmetto is not proven to improve urinary flow, prostate size, or hair loss.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Saw palmetto may help with prostate issues and hair loss.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Finasteride improves prostate cancer detection in PSA test.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Physical activity, height, and smoking affect prostate cancer risk.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.